X |
Filing Date |
Trade Date |
Ticker |
Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2024-09-13 | IGMS | Weber Steven | Principal Accounting Officer | S - Sale | $11.54 | -469 | 25,543 | -2% | -$5,412 | ||||||
2024-09-13 | IGMS | Takimoto Chris H | Chief Medical Officer | S - Sale | $11.54 | -1,487 | 154,331 | -1% | -$17,158 | ||||||
2024-09-13 | IGMS | Tahir Misbah | CFO | S - Sale | $11.54 | -1,487 | 122,694 | -1% | -$17,158 | ||||||
2024-09-13 | IGMS | Schwarzer Fred | CEO, Pres | S - Sale | $11.54 | -3,946 | 446,842 | -1% | -$45,532 | ||||||
2024-09-13 | IGMS | Keyt Bruce | Chief Scientific Officer | S - Sale | $11.54 | -1,487 | 246,987 | -1% | -$17,158 | ||||||
2024-09-13 | IGMS | Harler Mary Beth | Head, Research, Autoimmunity | S - Sale | $11.54 | -1,487 | 163,740 | -1% | -$17,158 | ||||||
2024-09-13 | IGMS | Decker Lisa Lynn | Chief Business Officer | S - Sale | $11.54 | -925 | 79,104 | -1% | -$10,673 | ||||||
| D | 2024-07-25 | IGMS | Hambleton Julie | Dir | S - Sale+OE | $14.00 | -15,132 | 2,000 | -88% | -$211,848 | |||||
2024-06-14 | IGMS | Weber Steven | Principal Accounting Officer | S - Sale | $7.58 | -495 | 26,012 | -2% | -$3,750 | ||||||
2024-06-14 | IGMS | Takimoto Chris H | Chief Medical Officer | S - Sale | $7.58 | -1,570 | 95,818 | -2% | -$11,893 | ||||||
2024-06-14 | IGMS | Tahir Misbah | CFO | S - Sale | $7.58 | -1,570 | 88,848 | -2% | -$11,893 | ||||||
2024-06-14 | IGMS | Schwarzer Fred | CEO, Pres | S - Sale | $7.58 | -4,164 | 450,788 | -1% | -$31,544 | ||||||
2024-06-14 | IGMS | Keyt Bruce | Chief Scientific Officer | S - Sale | $7.58 | -1,106 | 201,808 | -1% | -$8,378 | ||||||
2024-06-14 | IGMS | Harler Mary Beth | Head, Research, Autoimmunity | S - Sale | $7.58 | -1,570 | 85,227 | -2% | -$11,893 | ||||||
2024-06-14 | IGMS | Decker Lisa Lynn | Chief Business Officer | S - Sale | $7.58 | -977 | 60,029 | -2% | -$7,401 | ||||||
| M | 2024-03-26 | IGMS | Baker Bros. Advisors LP | Dir, 10% | P - Purchase | $8.67 | +395,317 | 3,753,480 | +12% | +$3,425,569 | |||||
| M | 2024-03-13 | IGMS | Weber Steven | Principal Accounting Officer | S - Sale | $10.01 | -993 | 26,507 | -4% | -$9,943 | |||||
| M | 2024-03-13 | IGMS | Takimoto Chris H | Chief Medical Officer | S - Sale | $10.01 | -5,424 | 94,388 | -5% | -$54,312 | |||||
| M | 2024-03-13 | IGMS | Tahir Misbah | CFO | S - Sale | $10.01 | -5,440 | 90,418 | -6% | -$54,472 | |||||
| M | 2024-03-13 | IGMS | Schwarzer Fred | CEO, Pres | S - Sale | $10.01 | -8,947 | 413,369 | -2% | -$89,588 | |||||
| M | 2024-03-13 | IGMS | Keyt Bruce | Chief Scientific Officer | S - Sale | $10.01 | -3,945 | 175,895 | -2% | -$39,502 | |||||
| M | 2024-03-13 | IGMS | Decker Lisa Lynn | Chief Business Officer | S - Sale | $10.01 | -3,376 | 61,006 | -5% | -$33,805 | |||||
2023-12-13 | IGMS | Schwarzer Fred | CEO, Pres | S - Sale | $5.78 | -17,576 | 299,566 | -6% | -$101,558 | ||||||
2023-12-13 | IGMS | Keyt Bruce | Chief Scientific Officer | S - Sale | $5.78 | -7,574 | 130,564 | -5% | -$43,764 | ||||||
2023-12-13 | IGMS | Decker Lisa Lynn | Chief Business Officer | S - Sale | $5.78 | -4,369 | 35,632 | -11% | -$25,245 | ||||||
| M | 2023-12-13 | IGMS | Baker Bros. Advisors LP | Dir, 10% | P - Purchase | $6.44 | +532,693 | 3,390,323 | +19% | +$3,431,464 | |||||
2023-11-29 | IGMS | Takimoto Chris H | Chief Medical Officer | S - Sale | $6.21 | -1,180 | 53,562 | -2% | -$7,331 | ||||||
2023-11-29 | IGMS | Gauthier George | Chief Commercial Officer | S - Sale | $6.21 | -1,180 | 39,642 | -3% | -$7,331 | ||||||
2023-11-29 | IGMS | Decker Lisa Lynn | Chief Business Officer | S - Sale | $6.21 | -1,180 | 40,001 | -3% | -$7,331 | ||||||
2023-11-27 | IGMS | Tahir Misbah | CFO | S - Sale | $5.06 | -1,337 | 49,608 | -3% | -$6,764 | ||||||
2023-11-27 | IGMS | Schwarzer Fred | CEO, Pres | S - Sale | $5.06 | -1,337 | 317,142 | 0% | -$6,764 | ||||||
2023-11-27 | IGMS | Keyt Bruce | Chief Scientific Officer | S - Sale | $5.06 | -933 | 138,138 | -1% | -$4,720 | ||||||
2023-10-02 | IGMS | Gauthier George | Chief Commercial Officer | S - Sale | $7.95 | -935 | 39,082 | -2% | -$7,430 | ||||||
2023-07-03 | IGMS | Gauthier George | Chief Commercial Officer | S - Sale | $9.42 | -936 | 40,017 | -2% | -$8,818 | ||||||
2023-06-30 | IGMS | Topsoe Christina Teng | Dir, 10% | P - Purchase | $9.32 | +3,000 | 10,449,807 | 0% | +$27,957 | ||||||
2023-06-29 | IGMS | Redmile Group, LLC | Dir | P - Purchase | $9.42 | +80,423 | 5,948,864 | +1% | +$757,585 | ||||||
2023-06-29 | IGMS | Redmile Group, LLC | Dir | S - Sale | $9.42 | -80,423 | 5,948,864 | -1% | -$757,585 | ||||||
| M | 2023-06-29 | IGMS | Topsoe Jakob Haldor | Dir, 10% | P - Purchase | $9.17 | +7,000 | 10,482,700 | 0% | +$64,222 | |||||
2023-06-26 | IGMS | Behrens M Kathleen | Dir | P - Purchase | $8.00 | +112,500 | 394,881 | +40% | +$900,000 | ||||||
2023-05-23 | IGMS | Takimoto Chris H | Chief Medical Officer | S - Sale | $12.31 | -1,259 | 54,742 | -2% | -$15,497 | ||||||
2023-05-23 | IGMS | Tahir Misbah | CFO | S - Sale | $12.31 | -1,259 | 50,711 | -2% | -$15,497 | ||||||
2023-05-23 | IGMS | Schwarzer Fred | CEO, Pres | S - Sale | $12.31 | -1,259 | 318,479 | 0% | -$15,497 | ||||||
2023-05-23 | IGMS | Keyt Bruce | Chief Scientific Officer | S - Sale | $12.31 | -982 | 139,071 | -1% | -$12,088 | ||||||
2023-05-23 | IGMS | Gauthier George | Chief Commercial Officer | S - Sale | $12.31 | -1,259 | 40,953 | -3% | -$15,497 | ||||||
2023-05-23 | IGMS | Decker Lisa Lynn | Chief Business Officer | S - Sale | $12.31 | -1,259 | 41,181 | -3% | -$15,497 | ||||||
| D | 2023-04-05 | IGMS | Gauthier George | Chief Commercial Officer | S - Sale+OE | $12.60 | -935 | 33,878 | -3% | -$11,781 | |||||
2023-03-14 | IGMS | Takimoto Chris H | Chief Medical Officer | S - Sale | $18.73 | -1,768 | 28,789 | -6% | -$33,118 | ||||||
2023-03-14 | IGMS | Tahir Misbah | CFO | S - Sale | $18.73 | -1,768 | 25,322 | -7% | -$33,118 | ||||||
2023-03-14 | IGMS | Keyt Bruce | Chief Scientific Officer | S - Sale | $18.73 | -1,293 | 91,717 | -1% | -$24,220 | ||||||
2023-03-14 | IGMS | Gauthier George | Chief Commercial Officer | S - Sale | $18.73 | -1,061 | 18,563 | -5% | -$19,875 | ||||||
2023-03-14 | IGMS | Decker Lisa Lynn | Chief Business Officer | S - Sale | $18.73 | -1,061 | 16,732 | -6% | -$19,875 | ||||||
2022-12-16 | IGMS | Takimoto Chris H | Chief Medical Officer | S - Sale | $18.98 | -5,430 | 30,557 | -15% | -$103,080 | ||||||
| M | 2022-12-16 | IGMS | Tahir Misbah | CFO | S - Sale | $19.62 | -6,084 | 27,090 | -18% | -$119,359 | |||||
2022-12-16 | IGMS | Schwarzer Fred | CEO, Pres | S - Sale | $18.98 | -12,369 | 217,078 | -5% | -$234,805 | ||||||
2022-12-16 | IGMS | Keyt Bruce | Chief Scientific Officer | S - Sale | $18.98 | -5,371 | 59,254 | -8% | -$101,960 | ||||||
2022-12-16 | IGMS | Gauthier George | Chief Commercial Officer | S - Sale | $18.98 | -4,354 | 19,624 | -18% | -$82,654 | ||||||
2022-12-16 | IGMS | Decker Lisa Lynn | Chief Business Officer | S - Sale | $18.98 | -2,484 | 17,793 | -12% | -$47,154 | ||||||
2022-11-23 | IGMS | Takimoto Chris H | Chief Medical Officer | S - Sale | $21.57 | -877 | 35,987 | -2% | -$18,918 | ||||||
2022-11-23 | IGMS | Tahir Misbah | CFO | S - Sale | $21.57 | -877 | 33,174 | -3% | -$18,918 | ||||||
2022-11-23 | IGMS | Schwarzer Fred | CEO, Pres | S - Sale | $21.57 | -1,258 | 229,447 | -1% | -$27,136 | ||||||
2022-11-23 | IGMS | Keyt Bruce | Chief Scientific Officer | S - Sale | $21.57 | -877 | 39,625 | -2% | -$18,918 | ||||||
2022-11-23 | IGMS | Gauthier George | Chief Commercial Officer | S - Sale | $21.57 | -1,258 | 23,978 | -5% | -$27,136 | ||||||
2022-11-23 | IGMS | Decker Lisa Lynn | Chief Business Officer | S - Sale | $21.57 | -1,258 | 20,277 | -6% | -$27,136 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |